Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT (HepASA)
This study has been terminated.
(interim analysis found no difference in LB rate and lower than expected event rate)
Sponsor:
Mount Sinai Hospital, Canada
Collaborators:
Canadian Institutes of Health Research (CIHR)
Pfizer
Information provided by:
Mount Sinai Hospital, Canada
ClinicalTrials.gov Identifier:
NCT00564174
First received: November 26, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | September 2005 |
| Estimated Primary Completion Date: | No date given |